2021
DOI: 10.1002/adtp.202100172
|View full text |Cite
|
Sign up to set email alerts
|

Recent Progress in Utilizing Upconversion Nanoparticles with Switchable Emission for Programmed Therapy

Abstract: Conventional upconversion nanoparticles (UCNPs) based nanoplatforms have achieved significant progress in many fields during the past decades, and with the development of nanoscience and nanotechnology, more and more complex situations need UCNPs based nanoplatforms due to their ability to load multiple molecules and also activate them independently when necessary. Only the UCNPs with switchable emission can meet this requirement. This review provides a summary of the optimization of synthetic approaches for t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 97 publications
0
4
0
Order By: Relevance
“…Traditional UCNPs with fixed emissions pose limitations in performing multiple tasks, while utilizing UCNPs with orthogonal emissive emissions (OUCNPs) makes it possible to independently control the photoactivation of different functions by simply adjusting the external excitation light. This capability allows for precise temporal control and targeting of multiple specific biological processes (Boyer et al, 2010;Wang et al, 2014;Wang et al, 2015b;Huang et al, 2018;Zheng et al, 2018;Zhang et al, 2021b;Zhang and Zhang, 2021). So far, the synthesis of OUCNPs is complicated and tedious because different lanthanides need to be incorporated into the different shells (Boyer et al, 2010;Lai et al, 2014;Wang et al, 2015b;Li et al, 2016;Dong et al, 2017;Mei et al, 2019;Lei et al, 2020).…”
Section: Programmable Therapeuticsmentioning
confidence: 99%
“…Traditional UCNPs with fixed emissions pose limitations in performing multiple tasks, while utilizing UCNPs with orthogonal emissive emissions (OUCNPs) makes it possible to independently control the photoactivation of different functions by simply adjusting the external excitation light. This capability allows for precise temporal control and targeting of multiple specific biological processes (Boyer et al, 2010;Wang et al, 2014;Wang et al, 2015b;Huang et al, 2018;Zheng et al, 2018;Zhang et al, 2021b;Zhang and Zhang, 2021). So far, the synthesis of OUCNPs is complicated and tedious because different lanthanides need to be incorporated into the different shells (Boyer et al, 2010;Lai et al, 2014;Wang et al, 2015b;Li et al, 2016;Dong et al, 2017;Mei et al, 2019;Lei et al, 2020).…”
Section: Programmable Therapeuticsmentioning
confidence: 99%
“…Over the past decades, UCNP-based nanoplatform for PDT has achieved great success both in vitro and in vivo. [10][11][12][13][14][15][16][17][18][19][20][21] Theory for practical cancer treatment PDT calls for not only for suitable light source to excite PSs but also enough ROS production to ensure high treatment efficacy. So far until now, the fully developed and widely applied PSs, such as methylene blue, zinc phthalocyanine, and chlorine e6 (Ce6), which belong to type-II (energy transfer types) PSs, and oxygen are necessary during their ROS production process.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, optical imaging plays a vital role in the biomedical field, and up to now, many optical agents such as quantum dots, organic dyes, , and upconversion nanoparticles have been applied to optical imaging and imaging-guided surgery. However, the imaging acquisition process is accompanied by an external light excitation at the same time, causing strong tissue autofluorescence, which consequently affects the imaging quantity and sensitivity, especially for in vivo imaging .…”
Section: Introductionmentioning
confidence: 99%